Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
196-210 of 4721 results
Purdue Pharma to invest in oncology research and development
Purdue Pharma says that it has finalized major oncology related investments as part of its move to diversify its scientific research into areas of high unmet medical need.
Drug Research > Drug Discovery & Development > News
Bayer and Loxo Oncology to develop and commercialize two cancer therapies
Bayer has entered into an exclusive global collaboration with Loxo Oncology for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195.
Drug Research > Drug Discovery & Development > News
EMA grants PRIME designation for Mereo’s BPS-804 to treat osteogenesis imperfecta
Mereo BioPharma Group’s BPS-804 has been granted PRIority MEdicines (PRIME) designation from the European Medicines Agency (EMA) for the treatment of osteogenesis imperfecta (OI), or "brittle bone disease."
Drug Research > Drug Discovery & Development > News
Research indicates potential treatment for autism and intellectual disability
A University of Nebraska Medical Center researcher and his team at the Munroe-Meyer Institute (MMI) made a breakthrough in finding the mechanism and a possible therapeutic fix for autism and intellectual disability
Drug Research > Drug Discovery & Development > News
Sanofi to develop Principia’s MS drug candidate in $805m deal
By PBR Staff Writer
Sanofi has agreed to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246) for the treatment of multiple sclerosis (MS) and possibly other central nervous system (CNS) diseases.
Drug Research > Drug Discovery & Development > News
Boehringer, MiNA Therapeutics partner to develop novel treatments for fibrotic liver diseases
By PBR Staff Writer
Boehringer Ingelheim has entered into collaboration and licensing agreement with MiNA Therapeutics for the development of novel treatments to treat fibrotic liver diseases.
Drug Research > Drug Discovery & Development > News
Cerenis Therapeutics acquires Lypro Biosciences
Cerenis Therapeutics has acquired Lypro Biosciences to expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery.
Drug Research > Drug Discovery & Development > News
New international consortium formed to speed up drug discovery in kidney diseases
By PBR Staff Writer
A new international consortium, including academic institutions such as the Universities of Bristol and Cambridge and drugmaker Evotec, has been established to enhance the discovery of drugs to treat kidney diseases.
Drug Research > Drug Discovery & Development > News
Spark Therapeutics, Pfizer amend license deal for investigational SPK-9001 in hemophilia B
Spark Therapeutics and Pfizer have entered into an amendment to their license agreement for SPK-9001, an investigational gene therapy for hemophilia B.
Drug Research > Drug Discovery & Development > News
Xenetic signs sublicense deal related to PolyXen technology with Baxalta
Xenetic Biosciences has entered into a Right to Sublicense Agreement with Baxalta, Baxalta, and Baxalta (collectively, with their affiliates, “Baxalta”), wholly-owned subsidiaries of Shire.
Drug Research > Drug Discovery & Development > News
Boehringer, Dicerna partner on RNAi treatment for NASH
By PBR Staff Writer
Boehringer Ingelheim and Dicerna Pharmaceuticals have partnered to develop treatments for chronic liver diseases including Nonalcoholic Steatohepatitis (NASH).
Drug Research > Drug Discovery & Development > News
Amgen to buy Japanese joint venture
By PBR Staff Writer
Amgen has entered an agreement to acquire Kirin-Amgen, its joint venture (JV) with Japan-based Kirin Holdings for $780m.
Drug Research > Drug Discovery & Development > News
Aviragen Therapeutics and Vaxart sign merger deal
By PBR Staff Writer
Aviragen Therapeutics, which is engaged in the discovery and development of direct-acting antivirals to treat infections with limited therapeutic options, has signed a merger agreement with Vaxart, a clinical-stage company focused on developing oral recombinant vaccines.
Drug Research > Drug Discovery & Development > News
Voyager to gain global rights to VY-AADC program for advanced Parkinson’s disease
Voyager Therapeutics, a clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, has announced an update to its VY-AADC program for advanced Parkinson’s disease.
Drug Research > Drug Discovery & Development > News
Researchers identify new genetic variants for breast cancer risk
A major international collaboration involving hundreds of researchers worldwide has identified seventy-two new genetic variants that contribute to the risk of developing breast cancer.
Drug Research > Drug Discovery & Development > News
196-210 of 4721 results